{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T05:30:57Z","timestamp":1783229457696,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20224ACB216016"],"award-info":[{"award-number":["20224ACB216016"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009102","name":"Education Department of Jiangxi Province","doi-asserted-by":"publisher","award":["GJJ201103"],"award-info":[{"award-number":["GJJ201103"]}],"id":[{"id":"10.13039\/501100009102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009102","name":"Education Department of Jiangxi Province","doi-asserted-by":"publisher","award":["GJJ211102"],"award-info":[{"award-number":["GJJ211102"]}],"id":[{"id":"10.13039\/501100009102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21967009"],"award-info":[{"award-number":["21967009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bmc.2022.117133","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:23:34Z","timestamp":1671189814000},"page":"117133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Design, synthesis and antitumor activity of novel thiophene- triazine derivatives bearing arylurea unit as potent PI3K\/mTOR inhibitorss"],"prefix":"10.1016","volume":"78","author":[{"given":"Shan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leixuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2022.117133_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA-Cancer J Clin"},{"key":"10.1016\/j.bmc.2022.117133_b0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: An overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bmc.2022.117133_b0015","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bmc.2022.117133_b0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jncimonographs\/lgv009","article-title":"Chemotherapy and cognitive function in breast cancer patients: the so-called chemo brain","author":"Hermelink","year":"2015","journal-title":"J National Cancer Institute. Monographs"},{"key":"10.1016\/j.bmc.2022.117133_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-019-1159-3","article-title":"On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer","volume":"21","author":"Bownes","year":"2019","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bmc.2022.117133_b0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.suronc.2019.09.001","article-title":"Progress in targeted therapeutic drugs for oral squamous cell carcinoma","volume":"31","author":"Liu","year":"2019","journal-title":"Surg Oncol"},{"key":"10.1016\/j.bmc.2022.117133_b0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.molonc.2012.02.004","article-title":"Discovery of small molecule cancer drugs: successes, challenges and opportunities","volume":"6","author":"Hoelder","year":"2012","journal-title":"Mol Oncol"},{"key":"10.1016\/j.bmc.2022.117133_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112995","article-title":"Gatzka The new opportunities in medicinal chemistry of fourth-generation EGFR inhibitors to overcome C797S mutation","volume":"210","author":"He","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.117133_b0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.semcancer.2019.05.012","article-title":"Role of the PI3K\/AKT\/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance","volume":"59","author":"Ediriweera","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bmc.2022.117133_b0050","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1039\/C5MB00101C","article-title":"The PI3K\/AKT\/mTOR interactive pathway","volume":"11","author":"Ersahin","year":"2015","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.bmc.2022.117133_b0055","first-page":"22","article-title":"PI3K\/AKT\/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects","author":"Miricescu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2022.117133_b0060","doi-asserted-by":"crossref","first-page":"10639","DOI":"10.2147\/OTT.S222967","article-title":"Osteoglycin (OGN) inhibits cell proliferation and invasiveness in breast cancer via PI3K\/Akt\/mTOR signaling pathway","volume":"12","author":"Xu","year":"2019","journal-title":"Oncotargets and Therapy."},{"key":"10.1016\/j.bmc.2022.117133_b0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ceb.2008.12.011","article-title":"PI3K and mTOR inhibitors - a new generation of targeted anticancer agents","volume":"21","author":"Brachmann","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.bmc.2022.117133_b0070","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1021\/acs.jmedchem.7b00357","article-title":"Design, synthesis, and biological evaluation of dimorpholine substituted thienopyrimidines as potential Class I PI3K\/mTOR dual inhibitors","volume":"60","author":"Zhan","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117133_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-018-1015-x","article-title":"A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer","volume":"20","author":"Schoffski","year":"2018","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bmc.2022.117133_b0080","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1158\/1078-0432.CCR-11-2088","article-title":"GDC-0941, a novel Class I selective PI3K inhibitor, enhances the efficacy of docetaxel in human breast cancer models by increasing cell death in vitro and in vivo","volume":"18","author":"Wallin","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2022.117133_b0085","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1021\/jm2009327","article-title":"Discovery of a potent, selective, and orally available Class I phosphatidylinositol 3-kinase (PI3K)\/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancer","volume":"54","author":"Sutherlin","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117133_b0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/1078-0432.CCR-17-1041","article-title":"PQR309 is a novel dual PI3K\/mTOR inhibitor with preclinical antitumor activity in lymphomas as a single agent and in combination therapy","volume":"24","author":"Tarantelli","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2022.117133_b0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1158\/1535-7163.MCT-14-0548","article-title":"Dual PI3K\/mTOR inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma","volume":"14","author":"Liu","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2022.117133_b0100","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1021\/jm901830p","article-title":"Bis(morpholino-1,3,5-triazine) derivatives: potent adenosine 5 '-triphosphate competitive phosphatidylinositol-3-kinase\/mammalian target of rapamycin inhibitors: discovery of compound 26 (PKI-587), a highly efficacious dual inhibitor","volume":"53","author":"Venkatesan","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117133_b0105","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1021\/jm400194n","article-title":"Pyrimidoaminotropanes as potent, selective, and efficacious small molecule kinase inhibitors of the mammalian target of rapamycin (mTOR)","volume":"56","author":"Estrada","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117133_b0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1021\/ml3003132","article-title":"Discovery and biological profiling of potent and selective mTOR inhibitor GDC-0349","volume":"4","author":"Pei","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2022.117133_b0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejmech.2016.03.033","article-title":"Design, synthesis, biological evaluation and docking studies of novel 2-substituted-4-morpholino-7, 8-dihydro-5H-thiopyrano [4, 3-d] pyrimidine derivatives as dual PI3K\u03b1\/mTOR inhibitors","volume":"116","author":"Lei","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.117133_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103525","article-title":"Design, synthesis and biological evaluation of substituted 2-(thiophen-2-yl)-1, 3, 5-triazine derivatives as potential dual PI3K\u03b1\/mTOR inhibitors","volume":"95","author":"Zhang","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2022.117133_b0125","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejmech.2015.01.061","article-title":"Design, synthesis and docking studies of novel thienopyrimidine derivatives bearing chromone moiety as mTOR\/PI3K\u03b1 inhibitors","volume":"93","author":"Zhu","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.117133_b0130","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1016\/j.bmc.2014.11.003","article-title":"Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano 4,3-d pyrimidine derivatives as mTOR inhibitors","volume":"22","author":"Zhu","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2022.117133_b0135","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1016\/j.bmc.2016.06.032","article-title":"Synthesis and anticancer activity of novel 4-morpholino-7,8-dihydro-5H-thiopyrano 4,3-d pyrimidine derivatives bearing chromone moiety","volume":"24","author":"Sun","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2022.117133_b0140","article-title":"Design, synthesis and biological evaluation of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing pyridazinone moiety as c-Met inhibitors","volume":"23","author":"Liu","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2022.117133_b0145","article-title":"Design, synthesis, and biological evaluation of 1,2,4 triazolo 4,3-a pyrazine derivatives as novel dual c-Met\/VEGFR-2 inhibitors","volume":"10","author":"Liu","year":"2022","journal-title":"Front Chem"},{"key":"10.1016\/j.bmc.2022.117133_b0150","article-title":"Design, synthesis and biological evaluation of 4-phenoxy-pyridine\/pyrimidine derivatives as dual VEGFR-2\/c-Met inhibitors","volume":"46","author":"Yang","year":"2022","journal-title":"New J Chem"},{"key":"10.1016\/j.bmc.2022.117133_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.135084","article-title":"Multifunctional MIL-101 nanoparticles with fenton-like reactions to co-deliver LL-37 peptide and vancomycin for targeted NIR imaging and drug-resistant bacteria treatment","volume":"435","author":"Lai","year":"2022","journal-title":"Chem Eng J"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622005260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622005260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:21:37Z","timestamp":1760836897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622005260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":31,"alternative-id":["S0968089622005260"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.117133","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and antitumor activity of novel thiophene- triazine derivatives bearing arylurea unit as potent PI3K\/mTOR inhibitorss","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.117133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117133"}}